Franklin India Technology Fund-Growth vs TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Franklin India Technology Fund-Growth appears stronger based on its higher star rating of 5 compared to TATA India Pharma & Healthcare Fund Direct Plan's rating of 2, indicating better overall performance and management quality. However, while Franklin's expense ratio is slightly higher at 1.16%, TATA's lower expense ratio of 1.1% may appeal to cost-conscious investors. For investors choosing between these funds, the takeaway is that while Franklin offers a higher rating, TATA has demonstrated better recent returns and lower costs.

Franklin Templeton Mutual Fund

Franklin India Technology Fund-Growth

Franklin Templeton Mutual Fund

★★★★★

Equity · Sectoral

Tata Mutual Fund

TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option

Tata Mutual Fund

★★★★★

Equity · Sectoral

Metric Franklin India Technol... TATA India Pharma & He...
NAV ₹544.36 ₹38.7
Star Rating ★★★★★ ★★
Expense Ratio 1.16% 1.1%
AUM ₹1,742 Cr ₹1,511 Cr
1M Return +5.45% +2.72%
3M Return -0.29% -3.21%
6M Return +13.03% +7.44%
1Y Return -5.8% +6.66%
3Y CAGR +10.29% +19.59%
5Y CAGR +7.22% +15.19%
Risk Level — —
Fund Manager Anand Radhakrishnan, Srikesh Nair, Varun Sharma Rupesh Patel, Sonam Udasi